265 related articles for article (PubMed ID: 30908557)
1. Full restoration of specific infectivity and strain properties from pure mammalian prion protein.
Burke CM; Walsh DJ; Steele AD; Agrimi U; Di Bari MA; Watts JC; Supattapone S
PLoS Pathog; 2019 Mar; 15(3):e1007662. PubMed ID: 30908557
[TBL] [Abstract][Full Text] [Related]
2. Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation.
Burke CM; Walsh DJ; Mark KMK; Deleault NR; Nishina KA; Agrimi U; Di Bari MA; Supattapone S
PLoS Pathog; 2020 Apr; 16(4):e1008495. PubMed ID: 32294141
[TBL] [Abstract][Full Text] [Related]
3. A Structural and Functional Comparison Between Infectious and Non-Infectious Autocatalytic Recombinant PrP Conformers.
Noble GP; Wang DW; Walsh DJ; Barone JR; Miller MB; Nishina KA; Li S; Supattapone S
PLoS Pathog; 2015 Jun; 11(6):e1005017. PubMed ID: 26125623
[TBL] [Abstract][Full Text] [Related]
4. Cofactor molecules: Essential partners for infectious prions.
Supattapone S
Prog Mol Biol Transl Sci; 2020; 175():53-75. PubMed ID: 32958241
[TBL] [Abstract][Full Text] [Related]
5. Dissociation of recombinant prion autocatalysis from infectivity.
Noble GP; Supattapone S
Prion; 2015; 9(6):405-11. PubMed ID: 26645356
[TBL] [Abstract][Full Text] [Related]
6. Isolation of infectious, non-fibrillar and oligomeric prions from a genetic prion disease.
Vanni I; Pirisinu L; Acevedo-Morantes C; Kamali-Jamil R; Rathod V; Di Bari MA; D'Agostino C; Marcon S; Esposito E; Riccardi G; Hornemann S; Senatore A; Aguzzi A; Agrimi U; Wille H; Nonno R
Brain; 2020 May; 143(5):1512-1524. PubMed ID: 32303068
[TBL] [Abstract][Full Text] [Related]
7. Identification of a homology-independent linchpin domain controlling mouse and bank vole prion protein conversion.
Burke CM; Mark KMK; Walsh DJ; Noble GP; Steele AD; Diack AB; Manson JC; Watts JC; Supattapone S
PLoS Pathog; 2020 Sep; 16(9):e1008875. PubMed ID: 32898162
[TBL] [Abstract][Full Text] [Related]
8. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
Kellershohn N; Laurent M
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
[TBL] [Abstract][Full Text] [Related]
9. Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein.
Leske H; Hornemann S; Herrmann US; Zhu C; Dametto P; Li B; Laferriere F; Polymenidou M; Pelczar P; Reimann RR; Schwarz P; Rushing EJ; Wüthrich K; Aguzzi A
PLoS One; 2017; 12(2):e0170503. PubMed ID: 28207746
[TBL] [Abstract][Full Text] [Related]
10. On the biology of prions.
Prusiner SB; Gabizon R; McKinley MP
Acta Neuropathol; 1987; 72(4):299-314. PubMed ID: 3554880
[TBL] [Abstract][Full Text] [Related]
11. Phosphorothioate oligonucleotides reduce PrP levels and prion infectivity in cultured cells.
Karpuj MV; Giles K; Gelibter-Niv S; Scott MR; Lingappa VR; Szoka FC; Peretz D; Denetclaw W; Prusiner SB
Mol Med; 2007; 13(3-4):190-8. PubMed ID: 17592554
[TBL] [Abstract][Full Text] [Related]
12. Non-genetic propagation of strain-specific properties of scrapie prion protein.
Bessen RA; Kocisko DA; Raymond GJ; Nandan S; Lansbury PT; Caughey B
Nature; 1995 Jun; 375(6533):698-700. PubMed ID: 7791905
[TBL] [Abstract][Full Text] [Related]
13. Reversible unfolding of infectious prion assemblies reveals the existence of an oligomeric elementary brick.
Igel-Egalon A; Moudjou M; Martin D; Busley A; Knäpple T; Herzog L; Reine F; Lepejova N; Richard CA; Béringue V; Rezaei H
PLoS Pathog; 2017 Sep; 13(9):e1006557. PubMed ID: 28880932
[TBL] [Abstract][Full Text] [Related]
14. Prion protein conversion in vitro.
Supattapone S
J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
[TBL] [Abstract][Full Text] [Related]
15. Novel mechanisms of degeneration of the central nervous system--prion structure and biology.
Prusiner SB; Stahl N; DeArmond SJ
Ciba Found Symp; 1988; 135():239-60. PubMed ID: 2900720
[TBL] [Abstract][Full Text] [Related]
16. Prion infection of epithelial Rov cells is a polarized event.
Paquet S; Sabuncu E; Delaunay JL; Laude H; Vilette D
J Virol; 2004 Jul; 78(13):7148-52. PubMed ID: 15194791
[TBL] [Abstract][Full Text] [Related]
17. Role of donor genotype in RT-QuIC seeding activity of chronic wasting disease prions using human and bank vole substrates.
Hwang S; Greenlee JJ; Nicholson EM
PLoS One; 2020; 15(1):e0227487. PubMed ID: 31910440
[TBL] [Abstract][Full Text] [Related]
18. Artificial strain of human prions created in vitro.
Kim C; Xiao X; Chen S; Haldiman T; Smirnovas V; Kofskey D; Warren M; Surewicz K; Maurer NR; Kong Q; Surewicz W; Safar JG
Nat Commun; 2018 Jun; 9(1):2166. PubMed ID: 29867164
[TBL] [Abstract][Full Text] [Related]
19. PrPc does not mediate internalization of PrPSc but is required at an early stage for de novo prion infection of Rov cells.
Paquet S; Daude N; Courageot MP; Chapuis J; Laude H; Vilette D
J Virol; 2007 Oct; 81(19):10786-91. PubMed ID: 17626095
[TBL] [Abstract][Full Text] [Related]
20. Prions amplify through degradation of the VPS10P sorting receptor sortilin.
Uchiyama K; Tomita M; Yano M; Chida J; Hara H; Das NR; Nykjaer A; Sakaguchi S
PLoS Pathog; 2017 Jun; 13(6):e1006470. PubMed ID: 28665987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
